CorMedix (CRMD) Finished Goods (2019 - 2025)

CorMedix (CRMD) reported Finished Goods of $14.4 million for Q4 2025, up 385.98% on a YoY basis from $3.0 million in Q4 2024, and up 12.27% sequentially from $12.8 million in Q3 2025.

CorMedix (CRMD) Finished Goods (2019 - 2025) Analysis & Trends

CorMedix (CRMD) has 5 years of Finished Goods data on file, last reported at $14.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods rose 385.98% year-over-year to $14.4 million; the trailing twelve-month figure through Dec 2025 stood at $14.4 million (up 385.98% YoY), and the FY2025 full-year result was $14.4 million, up 385.98% from the prior year.
  • Finished Goods rose to $14.4 million in Q4 2025, from $12.8 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $14.4 million in Q4 2025 to a low of $245668.0 in Q2 2021.
  • A 3-year average of $3.9 million and a median of $1.6 million in 2024 frame the typical range for Finished Goods.
  • Across the five-year window, Finished Goods tumbled 39.79% in 2021 and soared 1233.22% in 2025, its largest moves.
  • Tracing CRMD's Finished Goods over 3 years: stood at $245668.0 in 2021, then jumped by 1105.29% to $3.0 million in 2024, then soared by 385.98% to $14.4 million in 2025.
  • Business Quant data shows CRMD's Finished Goods at $14.4 million in Q4 2025, $12.8 million in Q3 2025, and $3.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.39 Mn
Sep 30, 2025 12.82 Mn
Jun 30, 2025 3.32 Mn
Mar 31, 2025 2.09 Mn
Dec 31, 2024 2.96 Mn
Sep 30, 2024 961,367.00
Jun 30, 2024 1.08 Mn
Mar 31, 2024 424,572.00
Jun 30, 2021 245,668.00
Mar 31, 2021 259,240.00
Dec 31, 2020 317,733.00
Sep 30, 2020 351,542.00
Jun 30, 2020 407,998.00
Mar 31, 2020 418,178.00
Dec 31, 2019 461,735.00